Filing Details
- Accession Number:
- 0001209191-11-015643
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-04 17:01:36
- Reporting Period:
- 2011-03-03
- Filing Date:
- 2011-03-04
- Accepted Time:
- 2011-03-04 17:01:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087432 | Intermune Inc | ITMN | Pharmaceutical Preparations (2834) | 943296648 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1206199 | G Daniel Welch | 3280 Bayshore Boulevard Brisbane CA 94005 | Chairman, Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-03-03 | 44,000 | $39.69 | 272,995 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was made pursuant to a 10b5-1 trading plan entered into in the first quarter of 2010 and in effect at the time of the transaction. The transaction was pre-determined in the trading plan to occur upon completion of a specific regulatory milestone. The shares sold in this transaction were acquired pursuant to a performance stock award granted in February of 2009, which vested upon approval of the Marketing Authorization Application for pirfenidone for the treatment of Idiopathic Pulmonary Fibrosis.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $39.23 to $40.02 per share. Full information on the numbers of shares sold at each sale price is available upon request.
Billionaire Hedge Funds
